Idarubicin hydrochloride and Ambisome drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Idarubicin hydrochloride (idarubicin hydrochloride) and Ambisome (amphotericin b). Common drug interactions include altered state of consciousness among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Idarubicin hydrochloride and Ambisome. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Idarubicin hydrochloride?
Idarubicin hydrochloride has active ingredients of idarubicin hydrochloride. eHealthMe is studying from 1,112 Idarubicin hydrochloride users. Check the latest studies of Idarubicin hydrochloride.
What is Ambisome?
Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,934 Ambisome users. Check the latest studies of Ambisome.
20 people who take Idarubicin hydrochloride and Ambisome together, and have interactions are studied.

What are the common drug interactions of Idarubicin Hydrochloride and Ambisome, by gender? *:
female:
- Altered state of consciousness (altered state of mind)
- Muscular weakness (muscle weakness)
- Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Vision blurred
- Febrile neutropenia (fever with reduced white blood cells)
- Parotitis (inflammation of a parotid gland)
- Respiratory tract infection
male:
- Pneumonia
- Pyrexia (fever)
- Drug ineffective
- Drug resistance (reduction in effectiveness of a drug)
- Abscess fungal (pus produced by a fungal infection)
- C-reactive protein increased
- Febrile neutropenia (fever with reduced white blood cells)
- Mycobacterial infection
- Myelosuppression (a decrease in the production of blood cells)
- Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
What are the common drug interactions of Idarubicin Hydrochloride and Ambisome, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Heart transplant
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Restrictive cardiomyopathy (a condition in which the walls of the lower chambers of the heart (the ventricles) are abnormally rigid and lack the flexibility)
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Bilirubin conjugated increased
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Pyrexia (fever)
- Transaminases increased
50-59:
- Altered state of consciousness (altered state of mind)
- Muscular weakness (muscle weakness)
- Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Vision blurred
- Opportunistic infection (a microorganism that normally does not cause disease but becomes pathogenic when the body's immune system is impaired and unable to fight)
- Renal failure (kidney dysfunction)
60+:
- Pneumonia
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Drug ineffective
- Drug resistance (reduction in effectiveness of a drug)
- Febrile neutropenia (fever with reduced white blood cells)
- Abscess fungal (pus produced by a fungal infection)
- C-reactive protein increased
- Mycobacterial infection
- Myelosuppression (a decrease in the production of blood cells)
- Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 85.00%
- Pneumonia Fungal: 4 people, 20.00%
- Bone Marrow Conditioning Regimen: 3 people, 15.00%
- Stress And Anxiety: 2 people, 10.00%
- Kidney Infection (Pyelonephritis): 2 people, 10.00%
- Cardiac Failure: 2 people, 10.00%
- Constipation: 2 people, 10.00%
- Fever: 2 people, 10.00%
- Gastrointestinal Candidiasis (fungal infection of gastrointestinal tract): 2 people, 10.00%
- Infection: 2 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Idarubicin hydrochloride and Ambisome?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Idarubicin hydrochloride (1,112 reports)
- Ambisome (7,934 reports)
Browse all drug interactions of Idarubicin hydrochloride and Ambisome:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Idarubicin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ambisome:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Idarubicin hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ambisome and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on idarubicin hydrochloride and amphotericin b (the active ingredients of Idarubicin hydrochloride and Ambisome, respectively), and Idarubicin hydrochloride and Ambisome (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Estrace cause Bone Metabolism Disorder? - 6 seconds ago
- Could Indomethacin cause Cardiac Failure Aggravated? - 27 seconds ago
- Drug interactions of Ibrance and Vinorelbine - 28 seconds ago
- Could Krill cause Taste - Impaired? - 35 seconds ago
- Drug interactions of Prednisone and Flax Seed - 36 seconds ago
- Drug interactions of Ibrance and Benadryl - 43 seconds ago
- Birth Control and Bone Density Decreased - 47 seconds ago
- Fungal Infection and Urticaria - 59 seconds ago
- Drug interactions of Hysingla Er and Ezetimibe - a minute ago
- Drug interactions of Zinc Chloride and Isoniazid - a minute ago